Adverse events among HIV/MDR-TB co-infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, India.

导出 OA

翻译打印收藏纠错

作者： Petros,Isaakidis ^[1] ; Bhanumati,Varghese ; Homa,Mansoor ; Helen S,Cox ; Joanna,Ladomirska ; Peter,Saranchuk ; Esdras,Da Silva ; Samsuddin,Khan ; Roma,Paryani ; Zarir,Udwadia ; Giovanni Battista,Migliori ; Giovanni,Sotgiu ; Tony,Reid

作者单位： Médecins Sans Frontières, Mumbai, India. msfocb-asia-epidemio@brussels.msf.org ^[1]

主题词成年人(Adult);抗HIV药(Anti-HIV Agents);抗结核药(Antitubercular Agents);女(雌)性(Female);HIV感染(HIV Infections);人类(Humans);印度(India);男(雄)性(Male);前瞻性研究(Prospective Studies);治疗结果(Treatment Outcome);结核, 抗多种药物性(Tuberculosis, Multidrug-Resistant)

DOI 10.1371/journal.pone.0040781

PMID 22792406

发布时间 2021-10-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览10

PloS one

2012年7卷7期

e40781页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Adverse events among HIV/MDR-TB co-infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, India.

PloS one

相似文献

PloS one

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Adverse events among HIV/MDR-TB co-infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, India.

PloS one

相似文献

PloS one

相关期刊

检索历史清除